一个单一的会话让他们都睡着了吗? 一次性干预治疗失眠的潜力
Matteo Carpi1, Erica Marie Szkody2, Daniel Ruivo Marques3,4
1Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
Journal of sleep research
|June 30, 2025
概括
单次疗程干预 (SSI) 对治疗常见的精神健康问题失眠有希望. 需要进一步的研究,以将这些成本效益高,灵活的方法整合到逐步护理模型中,以提高可访问性.
科学领域:
- 心理学 心理学 心理学
- 公共卫生 公共卫生
- 心理健康治疗 心理健康治疗
背景情况:
- 失眠是一种广泛的公共卫生问题,也是主要的心理健康障碍.
- 它预测抑郁症,并且经常与其他心理问题同时发生.
- 像认知行为疗法这样的当前治疗方法是有效的,但面临着可访问性的障碍.
研究的目的:
- 审查针对失眠的一次性干预 (SSI) 的证据.
- 探索SSI框架与失眠治疗需求之间的结合.
- 为了识别失眠的SSI整合的差距.
主要方法:
- 对针对失眠的一次性干预措施的现有文献进行系统审查.
- 分析SSI的理论基础和实际应用.
- 对基于失眠认知行为疗法的一次性干预的临床试验数据的检查.
主要成果:
- 对于各种心理健康状况,SSI是有效的,灵活的和具有成本效益的.
- 对失眠干预的几种一次性认知行为疗法在试验中显示出有希望的结果.
- 目前,将SSI纳入更广泛的失眠治疗框架是有限的.
结论:
- 该SSI框架很好地符合心理失眠治疗的需求.
- 需要进一步的研究来开发和验证基于共识的SSI治疗失眠.
- 在逐步护理模式中评估SSI的可行性和有效性对于改善可访问性至关重要.
相关概念视频
Management of Insomnia
328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
Insomnia
132
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
132
Sedatives and Hypnotics Drugs: Miscellaneous Agents
247
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
247
Blind Procedures
12.2K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.2K
Sedatives and Hypnotics: Overview
679
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
679
CNS Depressants: Barbiturates and Benzodiazepines
480
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
480


